06:58 AM EST, 02/13/2025 (MT Newswires) -- IDEAYA Biosciences ( IDYA ) reported a Q4 net loss Thursday of $1.49 per diluted share, compared with a loss of $0.52 a year earlier.

Analysts polled by FactSet expected a loss of $0.64.

Collaboration revenue for the quarter ended Dec. 31, 2024, was $7 million, up from $3.92 million a year earlier.

Analysts surveyed by FactSet expected $5.1 million.

The company said it had cash, cash equivalents, and marketable securities of $1.08 billion as of Dec. 31, 2024, compared with $632.6 million a year earlier, sufficient to fund operations until 2028.

The company's shares were up almost 4% in recent Thursday premarket activity.